Skip to main content
NewslettersWatchlist

Orthopediatrics Corp(KIDS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low31.36
Day High32.19
Open:31.70
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
PR Newswire
FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO
Motley Fool
3 Stocks to Buy and Hold for the Long Term
Globe Newswire
OrthoPediatrics Corp. Announces Proposed Offering of Common Stock and Pre-Funded Warrants
Globe Newswire
OrthoPediatrics Corp. Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
Motley Fool
2022 Roundtable: Our Favorite Picks Right Now
Globe Newswire
OrthoPediatrics Corp. to Report Second Quarter 2022 Financial Results on August 4, 2022
Globe Newswire
OrthoPediatrics Corp. Completes Acquisition of Pega Medical
Motley Fool
Buy the Dip on These 3 Healthcare Stocks
Globe Newswire
OrthoPediatrics Corp. Announces Deal to Acquire Pega Medical
Globe Newswire
OrthoPediatrics to Participate in The JMP Securities Life Sciences Conference
Globe Newswire
OrthoPediatrics Corp. Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
Globe Newswire
OrthoPediatrics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022
Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
Globe Newswire
OrthoPediatrics Corp. Announces Acquisition of MD Orthopaedics
Globe Newswire
OrthoPediatrics Corp. Reports Fourth Quarter and Record Full Year 2021 Financial Results
Globe Newswire
OrthoPediatrics Corp. Named One of the 2022 Best Places to Work in Indiana
Globe Newswire
OrthoPediatrics Corp. Celebrates 1,000th Case with FIREFLY® Pedicle Screw Navigation Guides
Globe Newswire
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022
Globe Newswire
OrthoPediatrics Announces Preliminary Unaudited Revenue for the Fourth Quarter & Full-Year 2021
Business Wire
Telos Partners LLC Welcomes Industry Veteran Scott Day as Senior VP and General Manager to Accelerate Growth Strategy
Globe Newswire
OrthoPediatrics Corp. Continued Double-Diamond Support of International Pediatric Orthopaedic Symposium (IPOS)
Globe Newswire
OrthoPediatrics to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference
Globe Newswire
OrthoPediatrics Corp. Reports Third Quarter 2021 Financial Results
Globe Newswire
OrthoPediatrics to Participate in the Stifel 2021 Virtual Healthcare Conference
Globe NewsWire
OrthoPediatrics Announces Entry into a Distribution Agreement with SeaSpine to Exclusively Distribute the 7D Surgical FLASH Navigation Platform for Pediatric Applications
Globe NewsWire
OrthoPediatrics Corp. Reports Second Quarter 2021 Financial Results
Globe NewsWire
OrthoPediatrics Corp. and Mighty Oak Medical Extend Exclusive Partnership for FIREFLY Technology in Pediatric Orthopedics
Globe NewsWire
OrthoPediatrics Corp. Maintains its Diamond Sponsorship for 31st Annual Baltimore Limb Deformity Course (“BLDC”)
Globe NewsWire
OrthoPediatrics Corp. to Report Second Quarter 2021 Financial Results on August 5, 2021
Globe NewsWire
OrthoPediatrics Corp. Announces Launch of Next Generation Cannulated Screw System
Globe NewsWire
OrthoPediatrics Corp. to Present at the 2021 JMP Securities Life Sciences Conference
Globe NewsWire
OrthoPediatrics Corp. Completes Senior Leadership Transition with Appointment of David Bailey as Chief Executive Officer

Profile

OrthoPediatrics Corp. is a medical device company. It markets surgical systems for trauma and deformity, bone fractures and reconstruction procedures. OrthoPediatrics Corp. is based in NEW YORK.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.